Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2017-04-04 2017-03-11
Drug Identification Number 02246859 02246859
Brand name APO-FENO-SUPER APO-FENO-SUPER
Common or Proper name FENOFIBRATE FENOFIBRATE
Company Name APOTEX INC APOTEX INC
Ingredients FENOFIBRATE FENOFIBRATE
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 BLS 100 BTL & 30 BLS
ATC code C10AB C10AB
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-01-31 2017-01-31
Estimated end date Unknown 2017-03-31
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments